← Back to all trials
Recruiting
NCT06330545
Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release
Conditions: Dupuytren Contracture
Sex: All
Ages: 45 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 95
Sponsor: Dartmouth-Hitchcock Medical Center
Location: Dartmouth Hitchcock Lebanon New Hampshire
Summary
The goal of this study is to learn about preventing recurrence of Dupuytren's Contracture. The main question it aims to answer are:
• Does targeted radiation therapy decrease recurrence of Dupuytren's contracture after treatment with Collagenase Clostridium Histolyticum?
Participants will undergo:
* Release of Dupuytren's Contracture after Collagenase Clostridium Histolyticum injection
* Daily radiation therapy treatment for 5 days followed by 6-8 week rest period and then another course of 5 days of radiation therapy
Eligibility Criteria
Inclusion Criteria:
* Age 45 or greater with DC
* Extension deficit \>10 degrees
* Unable to simultaneously place the affected finger and palm flat on a table.
* Women included in the study will be post-menopausal or using contraception, and a pregnancy test will be performed as standard of care.
* For patients who are having multiple CCH injections, only the first 2 joints on given hand will be included
Exclusion Criteria:
* Unsuccessful non-surgical release (\> N/1 disease)
* They develop an open wound during CCH
* Breast feeding or pregnancy
* A chronic muscular, neurologic, or neuromuscular disorder affecting the hands.
* Less than the age of 45
* They have previously undergone radiation on the hand in which they plan to get CCH injections
* They are pregnant women, impaired adults or prisoners
Source: ClinicalTrials.gov (NCT06330545). StuddyBuddy aggregates publicly available trial information.